Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. [electronic resource]
Producer: 20090331Description: 857-71 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Carrier Proteins -- genetics
- Class I Phosphatidylinositol 3-Kinases
- Esophageal Neoplasms -- genetics
- Female
- Genotype
- Humans
- Male
- Middle Aged
- PTEN Phosphohydrolase -- genetics
- Phosphatidylinositol 3-Kinases -- genetics
- Phosphotransferases (Alcohol Group Acceptor) -- genetics
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins c-akt -- genetics
- Radiotherapy
- Signal Transduction -- genetics
- TOR Serine-Threonine Kinases
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.